Diffusion Pharmaceuticals Inc.

NasdaqCM:DFFN Stock Report

Mkt Cap: US$12.7m

Diffusion Pharmaceuticals Financial Health

How is Diffusion Pharmaceuticals's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: DFFN's short term assets ($26.3M) exceed its short term liabilities ($2.3M).

Long Term Liabilities: DFFN has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: DFFN is debt free.

Reducing Debt: DFFN has no debt compared to 5 years ago when its debt to equity ratio was 8.7%.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: DFFN has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: DFFN has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 6.2% each year.


Discover healthy companies